“Imagene” that, Canadian system takes the lead in biomarker-driven mental health

July 18, 2009 by dendrite

While often the object of scorn from its capitalistic southern neighbor, the Canada Foundation for Innovation has just awarded Dr. David Kennedy a large research grant to deploy both neuroimaging and genetic markers in the development of personalised treatment for schizophrenia – through a program dubbed “neuroIMAGENE“. Dr. Kennedy suggests that this technological strategy may actually save money in the long run by helping physicians select the proper medication and dosage.

Enter your comment here...

Fill in your details below or click an icon to log in:

Email (required) (Address never made public)

Name (required)

Website

You are commenting using your WordPress.com account. ( Log Out / Change )

You are commenting using your Facebook account. ( Log Out / Change )

Connecting to %s

%d bloggers like this:

	Lockdown Link Dump… on The vagus nerve as a living Ku…
	PGC Lectures on Jung illuminates the fires of…
	How To Use 23andMe I… on rs1800955 survives meta-analyt…
	dendrite on Genomic solutions for really b…
	Neural Outlet.. on Genomic solutions for really b…
	cariaso on Are there genes for my favorit…
	dreambot on The vagus nerve as a living Ku…
	Aubrey de Grey Gets… on Movie star SIRT1 makes for a g…
	Kala Pierson on What is the sound of Aum?
	Jeremy Peirce on What is the sound of Aum?
	Alexei Morozov on red purple blue
	dendrite on Genetic testing across the US…
	dendrite on Genetic testing across the US…
	dendrite on Genetic testing across the US…
	rh on Genetic testing across the US…

Genes 2 Brains 2 Mind 2 Me